Coronary artery disease (CAD) and chronic kidney disease (CKD) frequently coexist, particularly in elderly populations. Their coexistence increases cardiovascular morbidity and mortality due to complex pathophysiological interactions such as accelerated atherosclerosis, endothelial dysfunction, oxidative stress, and disturbances in water-electrolyte balance. This study aims to optimize percutaneous coronary intervention (PCI) outcomes in patients with CAD and CKD by evaluating diagnostic approaches, procedural strategies, and peri-procedural management. We retrospectively analyzed 100 patients with CAD and CKD who underwent PCI between 2022 and 2024 at the Republican Specialized Scientific-Practical Medical Center of Surgery named after acad. V. Vakhidov. Data included demographics, CKD stage distribution, procedural details, and short-term outcomes. The majority of patients (46%) were in CKD stage 3, with a mean age of 64 years. PCI was associated with a high procedural success rate (>95%), while contrast-induced nephropathy (CIN) occurred in 9% of cases, predominantly in advanced CKD stages. Conclusion: Optimizing PCI in CKD patients requires a multidisciplinary approach, minimization of contrast volume, and close monitoring of renal function. Our findings support the integration of nephrology and cardiology expertise to improve outcomes in this high-risk group
Coronary artery disease (CAD) and chronic kidney disease (CKD) frequently coexist, particularly in elderly populations. Their coexistence increases cardiovascular morbidity and mortality due to complex pathophysiological interactions such as accelerated atherosclerosis, endothelial dysfunction, oxidative stress, and disturbances in water-electrolyte balance. This study aims to optimize percutaneous coronary intervention (PCI) outcomes in patients with CAD and CKD by evaluating diagnostic approaches, procedural strategies, and peri-procedural management. We retrospectively analyzed 100 patients with CAD and CKD who underwent PCI between 2022 and 2024 at the Republican Specialized Scientific-Practical Medical Center of Surgery named after acad. V. Vakhidov. Data included demographics, CKD stage distribution, procedural details, and short-term outcomes. The majority of patients (46%) were in CKD stage 3, with a mean age of 64 years. PCI was associated with a high procedural success rate (>95%), while contrast-induced nephropathy (CIN) occurred in 9% of cases, predominantly in advanced CKD stages. Conclusion: Optimizing PCI in CKD patients requires a multidisciplinary approach, minimization of contrast volume, and close monitoring of renal function. Our findings support the integration of nephrology and cardiology expertise to improve outcomes in this high-risk group
| № | Author name | position | Name of organisation |
|---|---|---|---|
| 1 | Zufarov M.M. | The Republican Specialized | Scientific and Practical Medical Center for Surgery named after Academician V. Vakhidov |
| 2 | Mahmudbekov M.O. | Scientific Advisor, Doctor of Medical Sciences, Professor | Scientific and Practical Medical Center for Surgery named after Academician V. Vakhidov |
| № | Name of reference |
|---|---|
| 1 | 1.Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. Kidney Int. 2011;80(6):572–586.2.Bangalore S, Maron DJ, O'Brien SM, et al. Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med. 2020;382:1608–1618.CKD Stage 583.Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:S11–S15.4.KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1–150.5.Tonelli M, Riella MC. Chronic kidney disease and the aging population. Nephrol Dial Transplant. 2014;29(1):1–5.6.Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305. |